Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved trial

AIMS: Biomarker‐driven prognostic models incorporating N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) and high‐sensitivity cardiac troponin T (hs‐cTnT) in heart failure (HF) with preserved ejection fraction (HFpEF) are lacking. We aimed to generate a biomarker‐driven prognostic tool for patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Pocock, Stuart J., Ferreira, João Pedro, Packer, Milton, Zannad, Faiez, Filippatos, Gerasimos, Kondo, Toru, McMurray, John J.V., Solomon, Scott D., Januzzi, James L., Iwata, Tomoko, Salsali, Afshin, Butler, Javed, Anker, Stefan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Focused Issue on Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796853/
https://www.ncbi.nlm.nih.gov/pubmed/35796209
http://dx.doi.org/10.1002/ejhf.2607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796853/
https://www.ncbi.nlm.nih.gov/pubmed/35796209
http://dx.doi.org/10.1002/ejhf.2607

Ejemplares similares